Ben Tre Pharmaceutical JSC (DBT) — Capital Reinvestment Ratio
Latest as of June 2020:
0.00x
Ben Tre Pharmaceutical JSC (DBT) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow (₫37.04 Billion) in capital expenditures (₫87.53 Million).
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
₫37.04 Billion
VND
Capital Expenditures
₫87.53 Million
VND
Data as of
Jun 2020
Most recent filing
Ben Tre Pharmaceutical JSC Capital Reinvestment Ratio (2016–2017)
This chart tracks Ben Tre Pharmaceutical JSC's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Ben Tre Pharmaceutical JSC (2016–2017)
Year-by-year Capital Reinvestment Ratio for Ben Tre Pharmaceutical JSC from 2016 to 2017.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.18x | ₫51.07 Billion | ₫9.02 Billion | ▲ +28.4% |
| 2016 | 0.14x | ₫32.71 Billion | ₫4.50 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow